(2014) analyzed a subset of mouse mutants with defective innate immunity-sensing signaling molecules and found that disruption of cGAS–STING, but not other receptors, reduced tumor CD8+ T cell infiltration and compromised host tumor control. The gene discussed is STING1; the disease is neoplasm.